Food science

Chief Scientist and Master of Wine join forces to consider the origins of Italian wine at Vinitaly 2024

Retrieved on: 
Wednesday, April 3, 2024
Financial management, Food science, Culture, Master, Accademia, Communication, Science, Genetics, Vino, Research, History, University, Master of Wine, Edmund Mach Foundation, Publication, Accademia Italiana, Book, Marketing, Agriculture, Viticulture

VERONA, Italy, April 3, 2024 /PRNewswire-PRWeb/ -- In this Advanced Seminar, entitled "Contemporary wines from old grape varieties", Professor Attilio Scienza and Andrea Lonardi MW discuss how winemaking culture and viticultural traditions have affected the evolution of Italian wines as we know them today, focusing on the influence of old vines, terroir and history. In a wide-ranging analyis, Profressor Scienza's presentation will shed light on vine genetics and the origins of certain native grape varieties. The seminar will be accompanied by a curated tasting involving some of Italy's most iconic grape varieties led by the recently certified Master of Wine, Andrea Lonardi.

Key Points: 
  • Professor Attilio Scienza, a leading academic in the field of vine science and Andrea Lonardi, a recently certified Master of Wine, join forces to consider the evolution of Italian wines with a particular focus on old vines, terroir and history.
  • In a wide-ranging analyis, Profressor Scienza's presentation will shed light on vine genetics and the origins of certain native grape varieties.
  • Since June 2018, Prof. Scienza has collaborated with Vinitaly International as the Chief Scientist of the Vinitaly International Academy.
  • A life-long learner and innovator with a global perspective, he became the second Italian MW in 2023.

Doctor's BiomeⓇ: Women's Health - Dietary Supplement Inhibited Pathogenic E. coli Bacteria and C. albicans Yeast

Retrieved on: 
Thursday, March 21, 2024
Food science, Urinary tract infection, Growth, Nutrition, Vaginal discharge, Health, Pelvic pain, Common, Journal, Candidiasis, UTI, Chills, Escherichia coli, Woman, Women's health, Infection, Fever, Urinary incontinence, Pain, Dietary supplement

Common UTI symptoms include urge and urinary incontinence, burning sensation while urinating, cloudy urine and pelvic pain.

Key Points: 
  • Common UTI symptoms include urge and urinary incontinence, burning sensation while urinating, cloudy urine and pelvic pain.
  • "Doctor's BiomeⓇ: Women's Health, is the first successful line extension of Doctor's BiomeⓇ.
  • Dr. Howard F. Robins, Chief Medical Officer of Doctor's BiomeⓇ explained "Our focus was to develop a proprietary dietary supplement for women that can inhibit both E. coli and C.
  • To develop Women's Health dietary supplement, we used Doctor's BiomeⓇ proprietary blend of five strains of Bifidobacteria and ten strains of Lactobacilli, as well as organic cranberry powder.

Nalu Bio Adds Top CPG Talent, Dondeena Bradley, to Board to Drive Adoption of No-High, Chemistry-Derived Cannabinoids for Health and Wellness

Retrieved on: 
Thursday, February 29, 2024
Well, SAN, Mental health, Woman, Fortune 500, Caregiver, Nutrition, Research, Health, Vitamin, Female, CPG, Global health, Food science, Cannabinoid, Harvard Business Review, Empathy, McKinsey & Company, Wellness, Health equity, Science, Public, Management

SAN FRANCISCO, Feb. 29, 2024 /PRNewswire/ -- Nalu Bio, a biotech company that is expanding health and wellness solutions through the development of no-high, chemistry-derived cannabinoid CPG ingredients, products, and therapeutic applications, proudly announces the appointment of Dondeena Bradley to its board of directors. With a distinguished career guiding health and wellness strategy, research and development, and wellbeing and nutrition-based innovations for the top global CPG companies, Dondeena brings invaluable expertise to drive an industry shift comparable to the introduction of vitamins 70 years ago—all while while closing the women's wellness gap—a $1 trillion opportunity to improve lives and economies globally.1

Key Points: 
  • "Dondeena brings valuable insights into CPG solution development and the pivotal stage for global health and wellness leaders' adoption of cannabinoids, making her an invaluable addition to our board," stated Caitlyn Krebs, Co-founder and CEO of Nalu Bio.
  • Dondeena joins Nalu Bio as the third female board member, including co-founders Caitlyn Krebs (CEO) and Phyllis Whiteley (Chairman of the Board), who collectively bring decades of pharmaceutical and healthcare experience that drive impact.
  • With Dondeena Bradley on its board, Nalu Bio is poised to lead the way in reshaping the future of consumer health and wellness.
  • As the first company to offer AI-powered combinations of cannabinoids and bioactives, Nalu Bio continues to drive advancements designed to impact global CPG companies' innovation pipelines.

Tate & Lyle Partners with Cryptobiotix: New ex-vivo study on low and no calorie sweeteners finds positive impact or no impact on human gut microbiota

Retrieved on: 
Thursday, February 15, 2024
Sorbitol, Erythritol, Stevia, Nutrition, Diet, Research, Molecular biology, Microbiota, Food, Potassium, Food science, Tate & Lyle, Drink, Psicose, Canadian International Council, Soft drink

Tate & Lyle PLC (Tate & Lyle), a world leader in ingredient solutions for healthier food and drink, partnered with Cryptobiotix, pioneers in preclinical gastrointestinal research, on the study.

Key Points: 
  • Tate & Lyle PLC (Tate & Lyle), a world leader in ingredient solutions for healthier food and drink, partnered with Cryptobiotix, pioneers in preclinical gastrointestinal research, on the study.
  • The doses of low and no calorie sweeteners used were based on actual intakes, regulations and amounts that are generally included in foods and beverages during different timepoints.
  • Assessments of additional low and no calorie sweeteners, including allulose and erythritol, are being completed and details will be shared in due course.
  • The low and no calorie sweeteners studied for this paper included: Acesulfame potassium (aceK), maltitol, sorbitol, stevia, sucralose and tagatose.

Believer Meats Expands Leadership Team as it Prepares for Next Phase of Commercialization

Retrieved on: 
Thursday, February 8, 2024
Science, Other Science, Agriculture, Natural Resources, Sustainability, Environment, Food, Beverage, Retail, Shook, Hardy & Bacon, Shook, Harvard Medical School, Bumble Bee Foods, IP, Meat, Food science, Food industry, University, Autoimmunity, Animal, Pairwise, Lawsuit, Record, AB InBev, Kraft Heinz, Anheuser-Busch, Marketing, Private sector, MBA, Veteran, Champaign–Urbana metropolitan area, Research, Doctor of Philosophy, Flexner Report, Head, Intellectual property, Management

These seasoned veterans bring extensive and complementary experience to the Believer Meats executive leadership team as the company continues to grow.

Key Points: 
  • These seasoned veterans bring extensive and complementary experience to the Believer Meats executive leadership team as the company continues to grow.
  • “Believer Meats is at an exciting inflection point as we enter a new phase of our commercialization in 2024,” says Gustavo Burger, CEO of Believer Meats.
  • Based in North Carolina, near Believer Meats’ forthcoming commercial-scale facility in Wilson, N.C., Hudson will play a pivotal role in the company’s expansion.
  • Elevating Hudson to this new leadership role underscores Believer Meats’ commitment to innovation and the pivotal role great products have in driving commercial success in the cultivated meat industry.

New ex-vivo study on low and no calorie sweeteners finds positive impact or no impact on human gut microbiota

Retrieved on: 
Thursday, February 8, 2024
Sorbitol, Psicose, Drink, Potassium, Molecular biology, Microbiota, Food science, Nutrition, Tate & Lyle, Stevia, Diet, Food, Research, Canadian International Council, Erythritol, Soft drink

Tate & Lyle and Cryptobiotix's breakthrough ex-vivo* study shows that sucralose does not impact the gut microbiota, while other low and no calorie sweeteners have potentially beneficial health effects

Key Points: 
  • Tate & Lyle and Cryptobiotix's breakthrough ex-vivo* study shows that sucralose does not impact the gut microbiota, while other low and no calorie sweeteners have potentially beneficial health effects
    LONDON, Feb. 8, 2024 /PRNewswire/ - A new, first-of-its-kind study has identified unique and potentially beneficial interactions between certain low and no calorie sweeteners, including stevia, and the human gut microbiota.
  • The doses of low and no calorie sweeteners used were based on actual intakes, regulations and amounts that are generally included in foods and beverages during different timepoints.
  • Assessments of additional low and no calorie sweeteners, including allulose and erythritol, are being completed and details will be shared in due course.
  • The low and no calorie sweeteners studied for this paper included: Acesulfame potassium (aceK), maltitol, sorbitol, stevia, sucralose and tagatose.

Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep

Retrieved on: 
Monday, February 5, 2024
Memory, Fermentation, GRAS, Dietary supplement, Clinical trial, Research, Cardiovascular disease, Ageing, Sleep, National university, Food science, FDA, Dementia, Functional food, Cosmetics, Longevity, Health, Frailty, Pennsylvania State University, Risk, Ergothioneine, Innovation, Plant, Drink

Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Blue California , an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine.

Key Points: 
  • Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Blue California , an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine.
  • A double-blinded placebo-controlled clinical trial sponsored by Blue California has shown that ErgoActive® ergothioneine supports aspects of cognitive function, memory, and sleep in healthy elderly subjects with subjective memory complaints.
  • "Blue California is proud to have sponsored such an important human study,” said Linda May-Zhang, Ph.D., VP of Science and Innovation at Blue California.
  • Today, Blue California has made a substantial advancement by sponsoring a double-blinded, placebo-controlled clinical study conducted at a national research institution.

Metavo™, The World's First Plant-Based, Metabolic Health Supplement Brand with AvoB™ Expands Product Offerings Designed to Address Additional Need States

Retrieved on: 
Thursday, December 7, 2023
Gluten-free diet, Associate, Associate professor, Vanilla, Weight loss, GMO, Amazon, University, Liver, Protein, Berberine, Metabolism, Glucose, Tops Friendly Markets, Health, Weis Markets, Organic, Chocolate, Mitochondrion, Fats, Vitacost, Food science, Powder, Support, Hunger, Veganism, HEB, Dietary supplement, BURLINGTON, Walgreens, Miner

BURLINGTON, ON, Dec. 7, 2023 /PRNewswire/ -- Today, SP Nutraceuticals unveiled three new product innovations under the Metavo™ brand across US retail, including Metavo™ Weight Support, Metavo™ Glucose Metabolism Support and Metavo™ Weight Support Meal Replacement Powders. The expansion comes soon after Metavo™ launched in North America as the world's first plant-based metabolism management supplement brand with AvoB.

Key Points: 
  • The expansion comes soon after Metavo™ launched in North America as the world's first plant-based metabolism management supplement brand with AvoB.
  • The innovations offer new ways for people to proactively support their metabolic health and activate their metabolism naturally to address specific need states like weight loss, glucose management, and meal replacements without losing lean muscle.
  • Metavo™ Weight Support Meal Replacement Powders - An innovative plant-based 'clean label' meal replacement powder designed to be the perfect 'metabolic' meal, which comes in both vanilla and chocolate and satisfies hunger.
  • Metavo™ Weight Support, Metavo™ Glucose Metabolism Support and Metavo™ Weight Support Meal Replacement Powders are all Project Verified Non-GMO, Gluten Free, and Vegan.

SP NUTRACEUTICALS ENTERS NEXT CHAPTER OF BUSINESS GROWTH WITH NEW INVESTMENT PARTNER, CHOPRAX VENTURES, AND APPOINTMENT OF NEW CEO AND BOARD OF DIRECTORS

Retrieved on: 
Tuesday, December 5, 2023
Medicine, Associate, Corporation, Research, University, SP, Risk, Fraud, Spagnuolo, Mastercard, Edelbrock, Metabolism, Health, CPG, Executive director, Shopping, Partnership, Growth, Food science, Family office, International Council, Family, Management, Pharmaceutical industry, BURLINGTON

BURLINGTON, ON, Dec. 5, 2023 /PRNewswire/ -- Today, SP Nutraceuticals announced a strategic partnership and equity agreement with ChopraX Ventures, led by its renowned clinician and Chairman Dr. Deepak Chopra, a pioneer at the forefront of medicine for the past 50 years. Simultaneously, SP Nutraceuticals announced a new slate of senior leadership and advisory members, including the appointment of Darren Contardo, current President of the company, as the new Chief Executive Officer, effective as of November 6, 2024. Darren will retain the President title. SP Nutraceuticals' flagship brand Metavo offers a suite of metabolism products which aim to support metabolic health.

Key Points: 
  • SP Nutraceuticals' flagship brand Metavo offers a suite of metabolism products which aim to support metabolic health.
  • "We are excited to collaborate with SP Nutraceuticals and actively pursue breakthrough innovations in metabolic health," said David Lubotta, Managing Partner of ChopraX Ventures.
  • "I am honored to step into the position of CEO of SP Nutraceuticals in this exciting phase of growth," said Darren Contardo, CEO of SP Nutraceuticals.
  • New board members include:
    Trevor Clarke, former CEO of SP Nutraceuticals, will now serve as the Executive Director and Corporate Secretary.

Red Ginseng's Potential as a Natural Treatment for Improving Withdrawal Symptoms and Dependency due to Drug Addiction Proven Scientifically

Retrieved on: 
Thursday, November 30, 2023
Research, Transitive dependency, Addiction, Culture of Korea, Liver, Mouse, Patient, Drug, Fentanyl, Glutathione, Non-alcoholic fatty liver disease, Morphine, Food science, Pharmaceutical industry, Dietary supplement

Prof. Oh Sei-kwan from Ewha Womans University College of Medicine found that the consumption of red ginseng reduces both physical and psychological dependency induced by drug addiction and greatly improves withdrawal symptoms.

Key Points: 
  • Prof. Oh Sei-kwan from Ewha Womans University College of Medicine found that the consumption of red ginseng reduces both physical and psychological dependency induced by drug addiction and greatly improves withdrawal symptoms.
  • With the global issue of drug addiction becoming increasingly serious, this research result garners even more anticipation.
  • In the absence of a clear cure for the escalating harms of drug addiction, the study on the effects of red ginseng in improving drug dependency is noteworthy.
  • This study scientifically proves the usefulness of red ginseng in treating drug addiction and confirms its potential as a natural treatment for substance dependency, marking an important milestone.